Trial
NCT00584909
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Uterine Cancer
Intervention
Paclitaxel and carboplatin combination
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-27